ReviewCurrent developments in nutrition2026
Consumer-Relevant Endpoints in Nutritional Supplement Research: A Case of Multivitamin and Mineral Supplements.
Review in Current developments in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multivitamin and mineral (MVM) supplements occupy a unique place in modern healthcare. They are one of only a few interventions the public actively embraces, despite clear guidelines that do not recommend routine MVM use for healthy people, because a balanced diet should provide all essential nutrients. This public adoption of MVMs creates a paradox when people say they take MVMs to support their well-being, yet scientific studies do not capture or measure what that actually entails. It also presents an opportunity to explore why this divergence exists, and in doing so, explore how people understand health and well-being. This review argues that trials of MVM supplementation in the general adult population are methodologically misaligned with the outcome consumers value, relying on endpoints and instruments that are neither representative nor sufficiently sensitive. Beyond any placebo effect, the summative effect of addressing multiple subclinical micronutrient deficiencies represents a potential, plausible biological basis for improved quality of life (QoL). Future MVM studies should be designed to comprehensively evaluate QoL and related outcomes (e.g., cognition, fatigue, and resilience) to align with reasons why adults take MVM supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.